We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
+11.76%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$156M
AUM Growth
–
Cap. Flow
+$147M
Cap. Flow %
94.35%
Top 10 Hldgs %
68.32%
Holding
24
New
24
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$13M
2
IQV icon
IQVIA
IQV
+$12.2M
3
AZN icon
AstraZeneca
AZN
+$12.2M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$11.9M
5
TMO icon
Thermo Fisher Scientific
TMO
+$11.7M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IQV icon
1
IQVIA
IQV
$40B
$13M 8.29%
+72,377
New +$12.2M
HUM icon
2
Humana
HUM
$46.2B
$12.8M 8.18%
+31,162
New +$13M
VRTX icon
3
Vertex Pharmaceuticals
VRTX
$132B
$12.3M 7.86%
+52,000
New +$11.9M
TMO icon
4
Thermo Fisher Scientific
TMO
$221B
$11.6M 7.4%
+24,851
New +$11.7M
AZN icon
5
AstraZeneca
AZN
$251B
$11.5M 7.36%
+115,050
New +$12.2M
ALNY icon
6
Alnylam Pharmaceuticals
ALNY
$29B
$11.2M 7.13%
+85,793
New +$11.5M
UTHR icon
7
United Therapeutics
UTHR
$22.7B
$10.6M 6.8%
+70,000
New +$9.19M
AXNX
8
DELISTED
Axonics, Inc. Common Stock
AXNX
$9.13M 5.84%
+182,840
New +$8.58M
NTRA icon
9
Natera
NTRA
$46.4B
$7.82M 5%
+78,600
New +$6.57M
BPMC
10
DELISTED
Blueprint Medicines
BPMC
$6.96M 4.45%
+62,060
New +$6.54M
ALXN
11
DELISTED
Alexion Pharmaceuticals
ALXN
$6.71M 4.29%
+42,929
New +$5.52M
ILMN icon
12
Illumina
ILMN
$29B
$5.81M 3.72%
+16,140
New +$5.15M
ARGX icon
13
argenx
ARGX
$54.2B
$5.76M 3.68%
+19,587
New +$5.38M
DXCM icon
14
DexCom
DXCM
$33.2B
$5.1M 3.26%
+55,200
New +$4.93M
ADPT icon
15
Adaptive Biotechnologies
ADPT
$4.09B
$4.94M 3.16%
+83,535
New +$4.31M
GH icon
16
Guardant Health
GH
$22.8B
$4.18M 2.68%
+32,460
New +$3.73M
OM icon
17
Outset Medical
OM
$94M
$4.09M 2.62%
+4,800
New +$3.7M
AGIO icon
18
Agios Pharmaceuticals
AGIO
$1.94B
$3.02M 1.93%
+69,700
New +$2.76M
CANO
19
DELISTED
Cano Health, Inc.
CANO
$2.52M 1.62%
+1,883
New +$2.15M
BFLY icon
20
Butterfly Network
BFLY
$2.6B
$2.26M 1.44%
+114,100
New +$1.46M
FDMT icon
21
4D Molecular Therapeutics
FDMT
$572M
$2.07M 1.33%
+50,000
New +$2.06M
DRNA
22
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.52M 0.97%
+69,000
New +$1.52M
SEER icon
23
Seer Inc
SEER
$121M
$1.12M 0.72%
+20,000
New +$1.27M
CMAX
24
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$421K 0.27%
+900
New +$302K

Similar funds

PIFP
Partners in Financial Planning Salem, Virginia $603M AUM 12.72% 1-Year Est. Return
IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return

Eagle Health Investments's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Eagle Health Investments, which disclosed 24 positions worth $156M. Its ten largest holdings account for 68% of the portfolio.

Its largest position is Humana: 31,162 shares worth $12.8M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets.

  • Eagle Health Investments's largest Q4 2020 buy was Humana: 31,162 shares worth $12.8M.
  • Eagle Health Investments's ten largest holdings make up 68% of its $156M portfolio in Q4 2020.
  • Eagle Health Investments disclosed 24 positions in Q4 2020, its first 13F filing on record.

Based on Eagle Health Investments's 13F filing for Q4 2020, filed 4 Feb 2021.